Anugerah 88

23.63

-0.09

|(-0.38%)

52W H: 47.6552W L: 22.3Beta: 0.65

About Mineralys Therapeutics Inc

Industry: Biotechnology
Exchange: NASDAQ NMS - GLOBAL MARKET
Country: US
Website: https://mineralystx.com/

Frequently Asked Questions

What is the 52-week range for MLYS?

The 52-week high is $47.65 and the 52-week low is $22.3.

What is the P/E ratio for MLYS?

The P/E ratio data is currently unavailable.

What is the dividend yield for MLYS?

This company does not currently pay a dividend or the data is unavailable.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is -57.97%.

What is the Net Profit Margin?

Net Margin data is currently unavailable.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 4.44.

Analyst Recommendation Trends

Wall Street analyst consensus for MLYS over the last few months:

2026-09-01

Buy: 9

S.Buy: 5

Hold: 2

Sell: 0

2026-08-01

Buy: 9

S.Buy: 5

Hold: 2

Sell: 0

2026-07-01

Buy: 9

S.Buy: 5

Hold: 2

Sell: 0

2026-06-01

Buy: 9

S.Buy: 5

Hold: 2

Sell: 0

Latest MLYS News

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

RADNOR, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that five abstracts will be presented at the American Heart Association (AHA) Hypertension Scientific Sessions 2026, taking plac

Yahoo10/1/2026

Mineralys Therapeutics To Present Five Abstracts At American Heart Association Hypertension Scientific Sessions 2026,

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney

Benzinga10/1/2026

Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

RADNOR, Pa., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced today that, on September 28, 2026, the Compensation Committee of Mineralys’ Board of Directors granted inducement stock option awards cover

Yahoo9/29/2026

Mineralys Therapeutics (MLYS) Faces A Fresh Valuation Test On New Lorundrostat Data

Why the latest lorundrostat data matters for Mineralys Therapeutics investors Mineralys Therapeutics (MLYS) is back on watch after the company flagged that long term efficacy and safety results from its Transform-HTN extension study of lorundrostat will feature in a late breaking session at the American Heart Association Scientific Sessions 2026. The latest lorundrostat update comes after a choppy stretch for Mineralys Therapeutics, with the share price falling 8.65% over the past week and...

Yahoo9/28/2026

Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum

RADNOR, Pa., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease, obstructive sleep apnea and other diseases driven by dysregulated aldosterone, announced today that management will be participating in the Stifel 2026 Virtual Cardiometabolic Forum taking place on September 30, 2026. Stifel 202

Yahoo9/24/2026

Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Scientific Sessions 2026

RADNOR, Pa., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced that new long-term efficacy and safety data from the Company’s ongoing Transform-HTN open-label extension trial of the al

Yahoo9/23/2026

Mineralys Therapeutics To Present New Long-Term Efficacy And Safety Data From Ongoing Transform-HTN Open-Label Extension Trial Of Aldosterone Synthase Inhibitor Lorundrostat At AHA Scientific Sessions 2026

Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in comorbid conditions such as chronic kidney

Benzinga9/23/2026

Mineralys: Why I'm Making Stock A Buy Ahead Of Hypertension Approval Decision

Mineralys is upgraded to Buy, with lorundrostat poised for FDA approval in December and a strong commercial launch anticipated. Read more on MLYS stock here.

SeekingAlpha9/3/2026

Related Stocks (Peers)

Companies operating in similar sectors to MLYS:

RXRX VERA ADMA MLYS BCRX VCEL ZBIO BHVN PVLA ABSI 950160.KQ

Recent Insider Transactions

Date	Name	Shares Changed	Price	Value
2026-09-22	Slingsby Brian Taylor	-104,320	$28.8085	$3,005,303
2026-09-21	Warren Eric	-7,438	-	-
2026-09-21	Warren Eric	-7,438	$28.1172	$209,136
2026-09-21	Warren Eric	+7,438	$13.24	$98,479
2026-09-15	Karydas Daphne	-3,000	-	-
2026-09-15	Karydas Daphne	-3,000	$28.58	$85,740
2026-09-15	Karydas Daphne	+3,000	$12.02	$36,060
2026-08-21	Warren Eric	-7,437	-	-
2026-08-21	Warren Eric	-7,437	$25.9767	$193,189
2026-08-21	Warren Eric	+7,437	$13.24	$98,466
2026-08-10	Ferguson James J. III	+135,000	-	-
2026-08-10	Ferguson James J. III	+102,400	-	-
2026-08-10	Rodman David Malcom	-2,170	-	-
2026-08-10	Rodman David Malcom	-2,170	$27.09	$58,785
2026-08-10	Rodman David Malcom	+2,170	$16	$34,720
2026-07-21	Warren Eric	-7,438	-	-
2026-07-21	Warren Eric	-7,438	$26.8735	$199,885
2026-07-21	Warren Eric	+7,438	$13.24	$98,479
2026-07-17	Rodman David Malcom	-416	-	-
2026-07-17	Rodman David Malcom	-416	$26.53	$11,036
2026-07-17	Rodman David Malcom	+416	$15.44	$6,423
2026-07-15	Rodman David Malcom	-6,349	$26.6112	$168,955
2026-07-13	Rodman David Malcom	-6,349	-	-
2026-07-13	Rodman David Malcom	-4,167	-	-
2026-07-13	Rodman David Malcom	-3,542	-	-
2026-07-13	Rodman David Malcom	-14,058	$27.5798	$387,717
2026-07-13	Rodman David Malcom	+6,349	$1.08	$6,857
2026-07-13	Rodman David Malcom	+4,167	$14.25	$59,380
2026-07-13	Rodman David Malcom	+3,542	$10.2	$36,128
2026-07-13	Congleton Jon	-10,700	$27.2375	$291,441
2026-07-09	Rodman David Malcom	-2,171	-	-
2026-07-09	Rodman David Malcom	-2,171	$30.3	$65,781
2026-07-09	Rodman David Malcom	+2,171	$16	$34,736
2026-06-12	Rodman David Malcom	-6,349	-	-
2026-06-12	Rodman David Malcom	-6,349	$23.9252	$151,901
2026-06-12	Rodman David Malcom	+6,349	$1.08	$6,857
2026-06-10	Rodman David Malcom	-2,170	-	-
2026-06-10	Rodman David Malcom	-2,170	$25	$54,250
2026-06-10	Rodman David Malcom	+2,170	$16	$34,720
2026-05-18	Rodman David Malcom	-417	-	-
2026-05-18	Rodman David Malcom	-417	$27.55	$11,488
2026-05-18	Rodman David Malcom	+417	$15.44	$6,438
2026-05-13	Rodman David Malcom	-4,166	-	-
2026-05-13	Rodman David Malcom	-3,541	-	-
2026-05-13	Rodman David Malcom	-14,056	$28.5849	$401,789
2026-05-13	Rodman David Malcom	+4,166	$14.25	$59,366
2026-05-13	Rodman David Malcom	+3,541	$10.2	$36,118
2026-05-12	Rodman David Malcom	-6,348	-	-
2026-05-12	Rodman David Malcom	-6,348	$29.3554	$186,348
2026-05-12	Rodman David Malcom	+6,348	$1.08	$6,856
2026-05-11	Rodman David Malcom	-2,171	-	-
2026-05-11	Rodman David Malcom	-2,171	$29.71	$64,500
2026-05-11	Rodman David Malcom	+2,171	$16	$34,736
2026-04-17	Rodman David Malcom	-416	-	-
2026-04-17	Rodman David Malcom	-416	$31.33	$13,033
2026-04-17	Rodman David Malcom	+416	$15.44	$6,423
2026-04-15	Rodman David Malcom	-6,348	$27.66	$175,586
2026-04-13	Rodman David Malcom	-4,167	-	-
2026-04-13	Rodman David Malcom	-3,542	-	-
2026-04-13	Rodman David Malcom	-6,349	-	-
2026-04-13	Rodman David Malcom	-14,058	$26.5391	$373,087
2026-04-13	Rodman David Malcom	+4,167	$14.25	$59,380
2026-04-13	Rodman David Malcom	+3,542	$10.2	$36,128
2026-04-13	Rodman David Malcom	+6,349	$1.08	$6,857
2026-04-13	Congleton Jon	-15,730	$26.8264	$421,979
2026-04-09	Rodman David Malcom	-2,170	-	-
2026-04-09	Rodman David Malcom	-2,170	$27.38	$59,415
2026-04-09	Rodman David Malcom	+2,170	$16	$34,720
2026-03-31	Karydas Daphne	-3,000	-	-
2026-03-31	Karydas Daphne	-3,000	$25	$75,000
2026-03-31	Karydas Daphne	+3,000	$12.02	$36,060
2026-03-31	Congleton Jon	-453	$27.0511	$12,254
2026-03-31	Congleton Jon	-55,183	$26.5385	$1,464,474
2026-03-31	Congleton Jon	-19,364	$25.5006	$493,794
2026-03-30	RA Capital Healthcare Fund LP	+58,300	$24.16	$1,408,528
2026-03-27	RA Capital Healthcare Fund LP	+310,700	$23.67	$7,354,269
2026-03-17	Rodman David Malcom	-417	-	-
2026-03-17	Rodman David Malcom	-417	$25.65	$10,696
2026-03-17	Rodman David Malcom	+417	$15.44	$6,438
2026-03-13	Rodman David Malcom	-4,167	-	-
2026-03-13	Rodman David Malcom	-3,542	-	-
2026-03-13	Rodman David Malcom	-253	$27.82	$7,038
2026-03-13	Rodman David Malcom	-3,079	$27.3675	$84,265
2026-03-13	Rodman David Malcom	-10,726	$25.9111	$277,922
2026-03-13	Rodman David Malcom	+4,167	$14.25	$59,380
2026-03-13	Rodman David Malcom	+3,542	$10.2	$36,128
2026-03-12	Rodman David Malcom	-6,348	-	-
2026-03-12	Rodman David Malcom	-6,348	$27.3705	$173,748
2026-03-12	Rodman David Malcom	+6,348	$1.08	$6,856
2026-03-09	Rodman David Malcom	-2,171	-	-
2026-03-09	Rodman David Malcom	-2,171	$26.84	$58,270
2026-03-09	Rodman David Malcom	+2,171	$16	$34,736
2026-02-19	Gold Alexander M	+8,300	-	-
2026-02-19	Gold Alexander M	+6,200	-	-
2026-02-19	Slingsby Brian Taylor	+8,300	-	-
2026-02-19	Slingsby Brian Taylor	-8,300	-	-
2026-02-19	Slingsby Brian Taylor	+8,300	-	-
2026-02-19	Slingsby Brian Taylor	+6,200	-	-
2026-02-19	Slingsby Brian Taylor	-6,200	-	-
2026-02-19	Slingsby Brian Taylor	+6,200	-	-
2026-02-19	Karydas Daphne	+8,300	-	-
2026-02-19	Karydas Daphne	+6,200	-	-
2026-02-19	DiRocco Derek	+8,300	-	-
2026-02-19	DiRocco Derek	+6,200	-	-
2026-02-19	Levy Adam Scott	+53,300	-	-
2026-02-19	Levy Adam Scott	+39,900	-	-
2026-02-19	Rodman David Malcom	+51,300	-	-
2026-02-19	Rodman David Malcom	+38,400	-	-
2026-02-19	Congleton Jon	+187,900	-	-
2026-02-19	Congleton Jon	+140,900	-	-
2026-02-19	RA Capital Healthcare Fund LP	+8,300	-	-
2026-02-19	RA Capital Healthcare Fund LP	+6,200	-	-
2026-02-19	SBLENDORIO GLENN	+8,300	-	-
2026-02-19	SBLENDORIO GLENN	+6,200	-	-
2026-02-19	AKKARAJU SRINIVAS	+8,300	-	-
2026-02-19	AKKARAJU SRINIVAS	+6,200	-	-
2026-02-17	Rodman David Malcom	-417	-	-
2026-02-17	Rodman David Malcom	-417	$27.59	$11,505
2026-02-17	Rodman David Malcom	+417	$15.44	$6,438
2026-02-13	Rodman David Malcom	-4,166	-	-
2026-02-13	Rodman David Malcom	-3,541	-	-
2026-02-13	Rodman David Malcom	-6,348	$27.5835	$175,100
2026-02-13	Rodman David Malcom	-4,166	$27.33	$113,857
2026-02-13	Rodman David Malcom	+4,166	$14.25	$59,366
2026-02-13	Rodman David Malcom	-3,541	$27.33	$96,776
2026-02-13	Rodman David Malcom	+3,541	$10.2	$36,118
2026-02-12	Rodman David Malcom	-6,349	-	-
2026-02-12	Rodman David Malcom	-521	$29.6387	$15,442
2026-02-12	Rodman David Malcom	-5,828	$28.9353	$168,635
2026-02-12	Rodman David Malcom	+6,349	$1.08	$6,857
2026-02-09	Rodman David Malcom	-2,171	-	-
2026-02-09	Rodman David Malcom	-2,171	$30.21	$65,586
2026-02-09	Rodman David Malcom	+2,171	$16	$34,736
2026-01-20	Rodman David Malcom	-416	-	-
2026-01-20	Rodman David Malcom	-416	$32.1	$13,354
2026-01-20	Rodman David Malcom	+416	$15.44	$6,423
2026-01-14	Rodman David Malcom	-11,367	$32.6071	$370,645
2026-01-13	Rodman David Malcom	-4,167	-	-
2026-01-13	Rodman David Malcom	-3,542	-	-
2026-01-13	Rodman David Malcom	-7,709	$32.75	$252,470
2026-01-13	Rodman David Malcom	+4,167	$14.25	$59,380
2026-01-13	Rodman David Malcom	+3,542	$10.2	$36,128
2026-01-12	Levy Adam Scott	-10,758	$32.1364	$345,723
2026-01-12	Rodman David Malcom	-6,348	-	-
2026-01-12	Rodman David Malcom	-6,348	$32.3162	$205,143
2026-01-12	Rodman David Malcom	+6,348	$1.08	$6,856
2026-01-12	Congleton Jon	-7,117	$33.1505	$235,932
2026-01-12	Congleton Jon	-9,119	$32.2083	$293,707
2026-01-09	Rodman David Malcom	-2,170	-	-
2026-01-09	Rodman David Malcom	-2,170	$33.27	$72,196
2026-01-09	Rodman David Malcom	+2,170	$16	$34,720
2026-01-05	Rodman David Malcom	-67,473	-	-
2026-01-05	Rodman David Malcom	-53,630	-	-
2026-01-05	Rodman David Malcom	-26,069	-	-
2026-01-05	Rodman David Malcom	-10,121	-	-
2026-01-05	Rodman David Malcom	-28,038	-	-
2026-01-05	Rodman David Malcom	-53,470	$35.5256	$1,899,554
2026-01-05	Rodman David Malcom	-139,245	$34.8275	$4,849,555
2026-01-05	Rodman David Malcom	+67,473	$14.25	$961,490
2026-01-05	Rodman David Malcom	+53,630	$16	$858,080
2026-01-05	Rodman David Malcom	+26,069	$10.2	$265,904
2026-01-05	Rodman David Malcom	+10,121	$15.44	$156,268
2026-01-05	Rodman David Malcom	+28,038	$1.08	$30,281
2026-01-02	Rodman David Malcom	-24,193	-	-
2026-01-02	Rodman David Malcom	-20,168	-	-
2026-01-02	Rodman David Malcom	-9,347	-	-
2026-01-02	Rodman David Malcom	-3,629	-	-
2026-01-02	Rodman David Malcom	-10,053	-	-
2026-01-02	Rodman David Malcom	-70,037	$35.8656	$2,511,919
2026-01-02	Rodman David Malcom	+24,193	$14.25	$344,750
2026-01-02	Rodman David Malcom	+20,168	$16	$322,688
2026-01-02	Rodman David Malcom	+9,347	$10.2	$95,339
2026-01-02	Rodman David Malcom	+3,629	$15.44	$56,032
2026-01-02	Rodman David Malcom	+10,053	$1.08	$10,857
2025-11-21	Congleton Jon	-24,082	-	-
2025-11-21	Congleton Jon	+24,082	$0.54	$13,004
2025-11-20	Catalys Pacific Fund, LP	-1,000,000	$43.35	$43,350,000
2025-11-13	Gold Alexander M	-10,000	-	-
2025-11-13	Gold Alexander M	-2,742	-	-
2025-11-13	Gold Alexander M	-12,742	$46.5	$592,503
2025-11-13	Gold Alexander M	+10,000	$12.69	$126,900
2025-11-13	Gold Alexander M	+2,742	$10.2	$27,968
2025-11-13	Karydas Daphne	-15,000	-	-
2025-11-13	Karydas Daphne	-4,885	$46.3554	$226,446
2025-11-13	Karydas Daphne	-10,115	$45.8083	$463,351
2025-11-13	Karydas Daphne	+15,000	$10.2	$153,000
2025-11-12	Gold Alexander M	-6,933	-	-
2025-11-12	Gold Alexander M	-1,933	$47.2766	$91,386
2025-11-12	Gold Alexander M	-5,000	$46.5	$232,500
2025-11-12	Gold Alexander M	+6,933	$10.2	$70,717
2025-11-11	Gold Alexander M	-15,000	-	-
2025-11-11	Gold Alexander M	-5,000	$47.0816	$235,408
2025-11-11	Gold Alexander M	-10,000	$42.4298	$424,298
2025-11-11	Gold Alexander M	+15,000	$10.2	$153,000
2025-11-11	Levy Adam Scott	-6,613	-	-
2025-11-11	Levy Adam Scott	-44,079	-	-
2025-11-11	Levy Adam Scott	-34,414	-	-
2025-11-11	Levy Adam Scott	-20,547	-	-
2025-11-11	Levy Adam Scott	-32,718	$46.8848	$1,533,977
2025-11-11	Levy Adam Scott	-38,900	$45.9277	$1,786,588
2025-11-11	Levy Adam Scott	-8,456	$45.1805	$382,046
2025-11-11	Levy Adam Scott	-4,142	$43.5015	$180,183
2025-11-11	Levy Adam Scott	-8,485	$42.3404	$359,258
2025-11-11	Levy Adam Scott	-12,952	$41.6522	$539,479
2025-11-11	Levy Adam Scott	-1,561	$42.6794	$66,623
2025-11-11	Levy Adam Scott	-11,295	$41.8709	$472,932
2025-11-11	Levy Adam Scott	-1,015	$42	$42,630
2025-11-11	Levy Adam Scott	+6,613	$15.44	$102,105
2025-11-11	Levy Adam Scott	+44,079	$14.25	$628,126
2025-11-11	Levy Adam Scott	+34,414	$16	$550,624
2025-11-11	Levy Adam Scott	+20,547	$10.2	$209,579
2025-11-11	Congleton Jon	-32,850	$46.8862	$1,540,212
2025-11-11	Congleton Jon	-112,275	$45.8335	$5,145,956
2025-11-11	Congleton Jon	-29,207	$45.2003	$1,320,165
2025-11-11	Congleton Jon	-4,000	$43.4959	$173,984
2025-11-11	Congleton Jon	-8,862	$42.3095	$374,947
2025-11-11	Congleton Jon	-12,806	$41.6395	$533,235
2025-10-15	Rodman David Malcom	-10,369	$43.0111	$445,982
2025-10-13	Levy Adam Scott	-3,392	$42.2561	$143,333
2025-10-13	Levy Adam Scott	-7,366	$41.9021	$308,651
2025-10-13	Congleton Jon	-1,552	$43.0299	$66,782
2025-10-13	Congleton Jon	-13,548	$42.6295	$577,544